DXCM vs. PODD: DexCom vs. Insulet Stock Comparison
How do DexCom (DXCM) and Insulet (PODD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
DexCom (DXCM) and Insulet (PODD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | DXCM | PODD |
|---|---|---|
| Name | DexCom Inc. | Insulet Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 29.62 billion USD | 10.16 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | Nasdaq |
| Listing Date | April 14, 2005 | May 15, 2007 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DXCM | PODD |
|---|---|---|
| Total Return (1Y) | 46.33% | -53.25% |
| Total Return (3Y, Annualized) | -4.50% | -0.74% |
| Total Return (5Y, Annualized) | -12.76% | -14.02% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | DXCM | PODD |
|---|---|---|
| Volatility (1Y, Annualized) | 38.37% | 46.33% |
| Beta (5Y) | 1.43 | 1.04 |
| Max Drawdown (5Y) | -66.32% | -63.02% |
| Avg. Volume (3M) | 4.34M | 1.58M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DXCM | PODD |
|---|---|---|
| Sharpe Ratio (1Y) | 1.10 | -1.24 |
| Sortino Ratio (1Y) | 1.79 | -1.51 |
Profitability
ROE (TTM)
Both DexCom (DXCM) at 37.67% and Insulet (PODD) at 28.94% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
PODD
Health Care Equipment & Services industry group
28.94%
- Max
- 47.61%
- PODD
- 28.94%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both DexCom (DXCM) at 19.42% and Insulet (PODD) at 13.44% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
PODD
Health Care Equipment & Services industry group
13.44%
- Max
- 29.35%
- PODD
- 13.44%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both DexCom (DXCM) at 24.34% and Insulet (PODD) at 22.54% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
PODD
Health Care Equipment & Services industry group
22.54%
- Max
- 35.43%
- PODD
- 22.54%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DXCM | PODD |
|---|---|---|
| ROE (TTM) | 37.67% | 28.94% |
| ROA (TTM) | 11.14% | 11.40% |
| Net Margin (TTM) | 19.42% | 13.44% |
| Operating Margin (TTM) | 24.34% | 22.54% |
| Gross Margin (TTM) | 63.42% | 71.88% |
Growth
Revenue Growth
Insulet (PODD) at 30.73% sits in the top revenue growth quartile, while DexCom (DXCM) at 15.60% is closer to the peer norm — faster top-line expansion for PODD.
EPS Growth
DexCom (DXCM) at 47.18% sits in the top EPS growth quartile, while Insulet (PODD) at -39.79% is in the bottom quartile, showing a clear gap in earnings momentum.
Growth Metrics
| Metric | DXCM | PODD |
|---|---|---|
| Revenue Growth (YoY) | 15.60% | 30.73% |
| Revenue Growth (3Y CAGR) | 17.01% | 27.54% |
| EPS Growth (YoY) | 47.18% | -39.79% |
| EPS Growth (3Y CAGR) | 36.60% | 267.70% |
Financial Strength
Current Ratio (MRQ)
Both DexCom (DXCM) at 1.74 and Insulet (PODD) at 2.51 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
PODD
Health Care Equipment & Services industry group
2.51
- Max
- 7.59
- Q3
- 4.00
- PODD
- 2.51
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both DexCom (DXCM) at 0.55 and Insulet (PODD) at 0.66 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
PODD
Health Care Equipment & Services industry group
0.66
- Max
- 1.88
- Q3
- 0.91
- PODD
- 0.66
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | DXCM | PODD |
|---|---|---|
| Current Ratio (MRQ) | 1.74 | 2.51 |
| Debt / Equity (MRQ) | 0.55 | 0.66 |
| Net Debt / EBITDA | -0.28 | 0.65 |
Dividends
Dividend Yield (TTM)
Neither DexCom (DXCM) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither DexCom (DXCM) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DXCM | PODD |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Both DexCom (DXCM) at 31.26 and Insulet (PODD) at 23.94 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
PODD
Health Care Equipment & Services industry group
23.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- PODD
- 23.94
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Insulet (PODD) at 3.19 is priced about in line with its industry on P/S ratio, while DexCom (DXCM) at 5.80 sits in the pricier quartile — DXCM costs more per dollar of sales.
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
PODD
Health Care Equipment & Services industry group
3.19
- Max
- 8.80
- Q3
- 4.32
- PODD
- 3.19
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Both DexCom (DXCM) at 11.68 and Insulet (PODD) at 6.44 carry a premium to book value versus peers, sitting in the upper P/B ratio quartile of their industries.
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
PODD
Health Care Equipment & Services industry group
6.44
- Max
- 11.68
- PODD
- 6.44
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DXCM | PODD |
|---|---|---|
| P/E Ratio (TTM) | 31.26 | 23.94 |
| P/S Ratio (TTM) | 5.80 | 3.19 |
| P/B Ratio (MRQ) | 11.68 | 6.44 |
| Free Cash Flow Yield (TTM) | 2.74% | 1.12% |